Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

5304 - "New treatments in Oncology: clinical practice regarding the management of Adverse Events (AEs)": results from a survey conducted by the Hellenic Group of Young Oncologists (HeGYO).

Date

10 Sep 2017

Session

Poster display session

Presenters

Michalis Liontos

Citation

Annals of Oncology (2017) 28 (suppl_5): v511-v520. 10.1093/annonc/mdx385

Authors

M. Liontos1, F. Koinis1, G. Chatsidis2, K. Kamposioras1, G. Papaxoinis1, M. Nikolaou1, K. Tsigaridas1, E. Voulgaris1, E. Pantavou1, G. Aravantinos1, A. Ardavanis1, I. Boukovinas1, E. Galani1, S. Angelaki1, G. Mountzios1, Z. Saridaki1, I. Varthalitis1, N. Tsoukalas1

Author affiliations

  • 1 On Behalf Of The Hellenic Group Of Young Oncologists (hegyo, Http://www.hesmo.gr/en/gyon/group), Under The Auspices Of The Hellenic Society Of Medical Oncology (hesmo, Http://www.hesmo.gr/en), On behalf of the Hellenic Group of Young Oncologists (HeGYO, http://www.hesmo.gr/en/gyon/group), under the auspices of the Hellenic Society of Medical Oncology (HeSMO, http://www.hesmo.gr/en), 11524 - Athens/GR
  • 2 Hellenic Group Of Young Oncologists (hegyo), Hellenic Group of Young Oncologists (HeGYO), 15351 - Athens/GR
More

Resources

Abstract 5304

Background

Targeted therapies with distinct toxicities have revolutionized treatment of advanced cancer. Aim of this study was to assess patterns of practice for the management of these AEs, which can impair patient’s(pts) quality of life and hamper compliance, potentially leading to treatment failure.

Methods

Between March 2017 and May 2017, an online questionnaire was distributed by HeGYO to oncologists to provide their answers anonymously.

Results

79 oncologists participated in the survey. The majority were medical oncologists (80%), 18% were clinical/radiation oncologists and 2% haematologists oncologists. Of them, 30% were in specialty training and 72% were ESMO members. Although 64.6% stated that they are very familiar with the new treatments in oncology, the majority (67.1%) spend less than 30% of their treatment initiation visit to inform pts on AEs. Only a minority (29.1%) gives diaries to pts for self reporting of AEs, but 59.4% offers educational material and 89.8% reaches proactively to pts. 53.2% do not make follow up phone calls between scheduled visits, while 58.2% report that there is not a call center service available in their institution for the pts to report AEs. More than 80% of oncologists described their practice to treat toxicities as more guideline-based than empiric and 92.4% of them were keen to refer pts to other medical specialties to optimize management of toxicities. 60.8% reported that a dose reduction or discontinuation was necessary in 10-30% of their pts and 59.5% reported that at least 1 of their pts discontinued treatment without informing them. Time constraints and the chaotic nature of web information were the predominant barriers interfering with doctor’s education.

Conclusions

This survey emphasizes the unmet need for continuous education among health professionals and pts and effective multidisciplinary collaboration for the optimization of AEs management. The majority of participants acknowledged the importance of informing their pts and treating their side effects according to guidelines. However, they describe significant obstacles in their daily practice.

Clinical trial identification

Legal entity responsible for the study

Hellenic Group of Young Oncologists (HeGYO), under the auspices of the Hellenic Society of Medical Oncology (HeSMO)

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.